Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy
Discrepancies between radiographic and pathological response assessments in NAT for PC may differ between NAC and NACRT. In reassessment after NAT, the specific type of therapy administered, that is, NAC or NACRT, must be considered, especially in cases wherein radiographic alterations are minimal.
Authors
- Daisaku Yamada (ORCID: https://orcid.org/0000-0002-6702-3800)
- Shogo Kobayashi (ORCID: https://orcid.org/0000-0002-8828-1067)
- Hirofumi Akita (ORCID: https://orcid.org/0000-0002-3115-9466)
- Yuichiro� Doki (ORCID: https://orcid.org/0000-0001-7346-0209)
- Takehiro Noda (ORCID: https://orcid.org/0000-0002-6768-5783)
- Hidenori Takahashi (ORCID: https://orcid.org/0000-0003-4801-3540)
- Hidetoshi Eguchi (ORCID: https://orcid.org/0000-0002-2318-1129)
- Yoshito Tomimaru (ORCID: https://orcid.org/0000-0002-4432-060X)
- Satoru Miyahara
Institutions
- The University of Osaka (JP)
Publication Details
- Journal
- Annals of Gastroenterological Surgery
- Published
- 2025-06-28
- DOI
- https://doi.org/10.1002/ags3.70047
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00